The tumor-targeting immunocytokine F16-IL2 in combination with doxorubicin: dose escalation in patients with advanced solid tumors and expansion into patients with metastatic breast cancer
2015 ◽
Vol 9
(1-2)
◽
pp. 14-21
◽
Chiara Catania
◽
Michela Maur
◽
Rossana Berardi
◽
Andrea Rocca
◽
Anna Maria Di Giacomo
◽
...
2017 ◽
Vol 23
(14)
◽
pp. 3529-3536
◽
Stacy L. Moulder
◽
Virginia F. Borges
◽
Tara Baetz
◽
Tessa Mcspadden
◽
Gina Fernetich
◽
...
Ana M. Gonzalez-Angulo
◽
Ian Krop
◽
Argun Akcakanat
◽
Huiqin Chen
◽
Shuying Liu
◽
...
D Juric
◽
G Argiles
◽
HA Burris
◽
AM Gonzalez-Angulo
◽
C Saura
◽
...
2001 ◽
Vol 19
(5)
◽
pp. 459-466
◽
Nuhad K. Ibrahim
◽
Vicente Valero
◽
Zia Rahman
◽
Richard L. Theriault
◽
Ronald S. Walters
◽
...
2018 ◽
Vol 9
(3)
◽
pp. 354-369
◽
Sheau W. Lok
◽
James R. Whittle
◽
François Vaillant
◽
Charis E. Teh
◽
Louisa L. Lo
◽
...
2010 ◽
Vol 120
(1)
◽
pp. 111-118
◽
Alejandra T. Perez
◽
Banu Arun
◽
Debu Tripathy
◽
Mary A. Tagliaferri
◽
Heather S. Shaw
◽
...
EC Dees
◽
PK Marcom
◽
A Snavely
◽
J Noe
◽
CK Anders
◽
...
S Loibl
◽
J Furlanetto
◽
J Barinoff
◽
D Bauerschlag
◽
D Herr
◽
...
Huiping Li
◽
Ran Ran
◽
Guohong Song
◽
Hanfang Jiang
◽
Ruyan Zhang
◽
...
Close
Export Citation Format
Close
Share Document
Close